SCHEMBL21614731

SCHEMBL21614731

COc1ccc(-c2ncc(CNc3ccnc(C(F)(F)F)c3)s2)cc1Cl

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.81
▸ CYP2C9 P11712 2/20 0.81
▸ KCNH2 Q12809 1/20 0.57
▸ CDK2 P24941 6/20 0.47
▸ GSK3B P49841 6/20 0.47
▸ MAPT P10636 4/20 0.38
▸ GAA P10253 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SMARCA2 P51531 1/20 0.36
▸ SMARCA4 P51532 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21614703 0.89 CYP2C19 (0.68) CYP2C19CYP2C9KCNH2CDK2GSK3B
SCHEMBL21614667 0.84 CYP2C19 (0.68) CYP2C19CYP2C9KCNH2MAPTLMNA
SCHEMBL21611951 0.83 CYP2C19 (0.81) CYP2C19CYP2C9KCNH2CDK2GSK3B
SCHEMBL21614700 0.82 CYP2C19 (0.66) CYP2C19CYP2C9KCNH2SMARCA2SMARCA4
SCHEMBL21614741 0.81 CYP2C19 (0.55) CYP2C19CYP2C9KCNH2CDK2GSK3B
SCHEMBL21612033 0.81 CYP2C19 (0.60) CYP2C19CYP2C9KCNH2MAPTLMNA
SCHEMBL21614772 0.78 CYP2C19 (0.75) CYP2C19CYP2C9KCNH2CYP1A2CYP3A4
SCHEMBL21612041 0.78 CYP2C19 (0.79) CYP2C19CYP2C9KCNH2
SCHEMBL21614677 0.77 CYP2C19 (0.60) CYP2C19CYP2C9KCNH2MAPTTP53
SCHEMBL30763501 0.77 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2CDK2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 CYP2C19 1824/4885CYP2C9 2997/4885KCNH2 2343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback